Ajanta Pharma Limited (BOM:532331)

Ajanta Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	45,318	42,087	37,426	33,410	28,897	25,879
Revenue Growth (YoY)	12.27%	12.45%	12.02%	15.62%	11.66%	25.91%
Cost of Revenue	11,062	11,210	11,102	8,840	6,832	6,896
Gross Profit	34,256	30,877	26,324	24,570	22,065	18,982
Selling, General & Admin	10,553	9,122	7,978	6,571	5,523	4,890
Other Operating Expenses	11,066	9,944	10,241	8,667	6,478	7,258
Operating Expenses	23,005	20,420	19,527	16,491	13,162	13,105
Operating Income	11,251	10,457	6,798	8,079	8,903	5,877
Interest Expense	-161.9	-72.1	-58.4	-102	-82.7	-119.1
Interest & Investment Income	277.1	277.1	84.6	146.5	35.1	44.1
Currency Exchange Gain (Loss)	91.7	158.7	660.7	563.7	45.1	745.3
Other Non Operating Income (Expenses)	465.2	264.1	61.5	323.8	40.9	68.7
EBT Excluding Unusual Items	11,923	11,084	7,546	9,011	8,941	6,616
Gain (Loss) on Sale of Investments	20.1	20.1	-40	122.8	82.7	63.8
Gain (Loss) on Sale of Assets	34.9	34.9	-53.5	-38.7	-22.1	-1
Other Unusual Items	-	-	-	-	-	-39.2
Pretax Income	11,978	11,139	7,453	9,095	9,002	6,640
Income Tax Expense	2,999	2,978	1,573	1,968	2,463	1,963
Net Income	8,979	8,162	5,880	7,127	6,539	4,677
Net Income to Common	8,979	8,162	5,880	7,127	6,539	4,677
Net Income Growth	22.04%	38.81%	-17.50%	8.99%	39.81%	20.86%
Shares Outstanding (Basic)	125	126	128	130	131	131
Shares Outstanding (Diluted)	125	126	128	130	131	131
Shares Change (YoY)	-0.87%	-1.65%	-1.19%	-0.74%	-0.21%	-0.85%
EPS (Basic)	71.61	64.82	45.89	54.97	50.06	35.73
EPS (Diluted)	71.57	64.77	45.89	54.96	50.06	35.73
EPS Growth	23.11%	41.14%	-16.50%	9.79%	40.10%	21.93%
Free Cash Flow	-	6,327	6,176	4,129	4,047	2,174
Free Cash Flow Per Share	-	50.21	48.21	31.84	30.98	16.60
Dividend Per Share	28.000	36.000	7.000	6.333	6.333	8.667
Dividend Growth	-22.22%	414.29%	10.53%	0%	-26.92%	44.45%
Gross Margin	75.59%	73.36%	70.34%	73.54%	76.36%	73.35%
Operating Margin	24.83%	24.84%	18.16%	24.18%	30.81%	22.71%
Profit Margin	19.81%	19.39%	15.71%	21.33%	22.63%	18.07%
Free Cash Flow Margin	-	15.03%	16.50%	12.36%	14.00%	8.40%
EBITDA	12,453	11,638	7,952	9,173	9,889	6,673
EBITDA Margin	27.48%	27.65%	21.25%	27.45%	34.22%	25.78%
D&A For EBITDA	1,202	1,181	1,154	1,094	985.9	795.5
EBIT	11,251	10,457	6,798	8,079	8,903	5,877
EBIT Margin	24.83%	24.84%	18.16%	24.18%	30.81%	22.71%
Effective Tax Rate	25.04%	26.73%	21.10%	21.64%	27.36%	29.56%
Revenue as Reported	46,437	42,933	38,413	34,567	29,157	26,801
Advertising Expenses	-	44.9	50.2	47.8	16.2	14

Source: S&P Capital IQ. Standard template. Financial Sources.